Neurology Inpatient Clinical Education Trial

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

December 7, 2021

Study Completion Date

December 7, 2021

Conditions
Myasthenia GravisGuillain-Barre SyndromeMultiple SclerosisSeizuresParkinsonismMeningitisEncephalitisHeadacheVestibular DisorderSpondylosisNormal Pressure Hydrocephalus
Interventions
BEHAVIORAL

Current standard discharge educational intervention

The patients will receive the current hospital standard discharge educational material which explains the diagnosis, new medications, follow up and any activity/diet restrictions. A member of the study team will explain this material to the patient and answer any questions.

BEHAVIORAL

Personalized discharge educational intervention

The patients will receive a new personalized discharge educational material which will explain the specifics of their disorder, the treatment, and prognosis. The materials will contain simple, organized explanations and graphics. A member of the study team will explain this material to the patient and answer any questions.

Trial Locations (1)

03756

Dartmouth- Hitchcock Medical Center, Lebanon

All Listed Sponsors
lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT03826056 - Neurology Inpatient Clinical Education Trial | Biotech Hunter | Biotech Hunter